Bladder cancer is a challenging disease that poses significant risks to patients, often leading to a grim prognosis. Recent research has brought attention to chaperonin-containing tailless complex polypeptide 1 subunit 3 (CCT3), identified as an oncogene in multiple tumor types. However, its specific role in bladder cancer remains largely unexplored.